Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on May 13, 2026

May 13, 2026

Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion

Indeterminate GlobeNewswire

May 13, 2026

Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

Indeterminate GlobeNewswire

May 13, 2026

Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Indeterminate GlobeNewswire

May 13, 2026

Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Indeterminate GlobeNewswire

May 13, 2026

Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer

Indeterminate GlobeNewswire

May 13, 2026

Century Therapeutics Reports First Quarter Financial Results and Business Updates 

Indeterminate GlobeNewswire

May 13, 2026

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Indeterminate GlobeNewswire

May 13, 2026

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026

Indeterminate GlobeNewswire

May 13, 2026

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

Indeterminate GlobeNewswire

May 13, 2026

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

Indeterminate GlobeNewswire

May 13, 2026

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

Indeterminate GlobeNewswire

May 13, 2026

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial

Indeterminate GlobeNewswire

May 13, 2026

Abacus Global Management to Participate in the 26th Annual B. Riley Investor Conference

Indeterminate GlobeNewswire

May 13, 2026

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Indeterminate GlobeNewswire

May 13, 2026

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire

May 13, 2026

Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks

Indeterminate GlobeNewswire

May 13, 2026

Outdoor Innovation Awards Program Proudly Announces Featured Winners In 3rd Annual Awards Program

Indeterminate GlobeNewswire

May 13, 2026

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President

Indeterminate GlobeNewswire

May 13, 2026

Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus

Indeterminate GlobeNewswire

May 13, 2026

Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药

Indeterminate GlobeNewswire